We thus demonstrated that CSF-CXCL13 is significantly increased in multiple sclerosis/ON/CIS/NMOSD patients with both clinical activity regarding new relapse symptoms and magnetic resonance imaging activity with new gadolinium-enhancing T1 lesions. This evidence concerns the gene CXCL13 and multiple sclerosis.